Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Down 4.4% – Time to Sell?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) dropped 4.4% during trading on Friday . The stock traded as low as $15.60 and last traded at $15.62. Approximately 3,839 shares were traded during mid-day trading, a decline of 79% from the average daily volume of 18,023 shares. The stock had previously closed at $16.34.

Wall Street Analysts Forecast Growth

TLX has been the topic of a number of recent research reports. UBS Group started coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research report on Friday, November 15th. They set a “buy” rating and a $21.00 price objective on the stock. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.